What is NDC 0409-7391?

0409-7391 is the product NDC for Sodium Phosphates, Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Sodium Phosphates (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS).

What is the active ingredient?

Sodium phosphate, Monobasic, Monohydrate, Sodium phosphate, Dibasic, Anhydrous.

Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sodium Phosphates?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sodium Phosphates NDC 0409-7391 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-7391Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-7391Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-7391-72	0040973917200409739172	25 VIAL, SINGLE-DOSE in 1 TRAY (0409-7391-72) / 15 mL in 1 VIAL, SINGLE-DOSE (0409-7391-82)Marketed from Jun 2, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Phosphates
Generic name (nonproprietary): sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous
Active ingredients: Sodium phosphate, Monobasic, Monohydrate — 276 mg/mLSodium phosphate, Dibasic, Anhydrous — 142 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hospira, Inc.NDC labeler code 0409
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018892
Marketing start: Jun 2, 2005
Listing expires: Dec 31, 2027
Identifiers: Product ID 0409-7391_1c2e7887-159f-46be-8cda-88851394ea9eSPL ID 1c2e7887-159f-46be-8cda-88851394ea9eSPL set ID 6f044d16-295e-43ff-72a3-b045c387bc5cRxCUI 1872384UNII 593YOG76RN, 22ADO53M6F

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409739172 followed by a unit qualifier and the quantity

Package 00409-7391-72. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 11, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sodium Phosphates Injection, USP, 3 mM P/mL is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (Na + 4 mEq/mL) must be calculated into total electrolyte dose of such prepared solutions.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0409-7391

What is NDC 0409-7391?: 0409-7391 is the product NDC for Sodium Phosphates, Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sodium Phosphates (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS).
What is the active ingredient?: Sodium phosphate, Monobasic, Monohydrate, Sodium phosphate, Dibasic, Anhydrous.
Who is the labeler?: Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sodium Phosphates?: 14 other product NDCs are listed under this name. See all Sodium Phosphates NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sodium Phosphates NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-200	65145-0200-25
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-201	65145-0201-25
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-202	65145-0202-25
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-728	68462-0728-25
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-729	68462-0729-25
Sodium Phosphates	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-730	68462-0730-25
Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL	Injection, SolutionIntravenous	Civica, Inc.	72572-309	72572-0309-25
Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-7305	00517-7305-25
Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-7315	00517-7315-25
Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous	Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-7350	00517-7350-25

All 15 Sodium Phosphates NDCs